Sana Biotechnology, Inc. (SANA) Operating income 2019–2025
Sana Biotechnology, Inc. (SANA) annual operating income history from SEC filings — each fiscal year as reported.
-$250.3MFY2025 · since FY2019: -$141.2M → -$250.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$250.3M | +8.2% |
| FY2024 | -$272.7M | +7.0% |
| FY2023 | -$293.1M | -7.5% |
| FY2022 | -$272.6M | +23.6% |
| FY2021 | -$356.9M | -24.7% |
| FY2020 | -$286.1M | -102.7% |
| FY2019 | -$141.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SANA financial trends
SANA RevenueSANA Net incomeSANA Net marginSANA Gross profitSANA Gross marginSANA Operating marginSANA Operating cash flowSANA Free cash flowSANA Capital expendituresSANA Return on equitySANA Stock buybacksSANA Dividends paidSANA Total assetsSANA Total liabilitiesSANA Shareholders’ equitySANA overview →